PharmaTher | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25 results for “PharmaTher”

Trials

Not yet recruiting

Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol

154 participants · First posted Jun 29, 2025

Drugs

Ketamine+betaine microneedle patch (PharmaTher)

Lysergic acid diethylamide

C₂₀H₂₅N₃O

Enoxaparin sodium biosimilar (Pharmathen)

Organizations

View all 10 →

Pharmather, Inc.

Canada

PHARMATHEN S.A.

Greece

Pharmathen SA

Greece

News

PharmaTher Secures U.S. Patent for Advanced Ketamine Production Technology

PharmaTher Secures Exclusive Rights to Long-Acting Injectable Ketamine Technology for Treatment-Resistant Depression

PharmaTher Receives FDA Goal Date of October 29, 2024 for Priority Ketamine ANDA Approval

Page 1 of 3